The Enterprise Value as of December 2025 (TTM) for BioInvent International AB (publ) (BOVNF) is 1.43B

According to BioInvent International AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 1.43B. This represents a change of -17.83% compared to the average of 1.74B of the last 4 quarters.

BioInvent International AB (publ) (BOVNF) Historical Enterprise Value (quarterly & annually)

How has BOVNF Enterprise Value performed in the past?

The mean historical Enterprise Value of BioInvent International AB (publ) over the last ten years is 932.08M. The current 1.43B Enterprise Value has changed 15.20% with respect to the historical average. Over the past ten years (40 quarters), BOVNF's Enterprise Value was at its highest in in the September 2024 quarter at 2.47B. The Enterprise Value was at its lowest in in the March 2016 quarter at 296.97M.

BioInvent International AB (publ) (BOVNF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioInvent International AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioInvent International AB (publ) (BOVNF) Average Enterprise Value

How has BOVNF Enterprise Value performed in the past?

The current Enterprise Value of BioInvent International AB (publ) (BOVNF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioInvent International AB (publ) (BOVNF) Enterprise Value vs. Peers

How is BOVNF’s Enterprise Value compared to its peers?

BioInvent International AB (publ)’s Enterprise Value is greater than Avacta Group Plc (355.89M), greater than MedinCell S.A. (859.57M), less than Healios K.K. (39.39B), greater than Race Oncology Limited (482.80M), greater than PureTech Health plc (150.89M), greater than Northwest Biotherapeutics, Inc. (439.79M), greater than CytoDyn Inc. (438.46M), greater than Immutep Limited (316.92M), greater than GenSight Biologics S.A. (36.30M), greater than Clinuvel Pharmaceuticals Limited (394.46M),

Build a custom stock screener for BioInvent International AB (publ) (BOVNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioInvent International AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioInvent International AB (publ) (BOVNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioInvent International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.